BRPI1009447A2 - métodos de purificação de proteínas imunofarmacêuticas modulares pequenas - Google Patents

métodos de purificação de proteínas imunofarmacêuticas modulares pequenas

Info

Publication number
BRPI1009447A2
BRPI1009447A2 BRPI1009447A BRPI1009447A BRPI1009447A2 BR PI1009447 A2 BRPI1009447 A2 BR PI1009447A2 BR PI1009447 A BRPI1009447 A BR PI1009447A BR PI1009447 A BRPI1009447 A BR PI1009447A BR PI1009447 A2 BRPI1009447 A2 BR PI1009447A2
Authority
BR
Brazil
Prior art keywords
protein purification
purification methods
small modular
modular immunopharmaceutical
immunopharmaceutical protein
Prior art date
Application number
BRPI1009447A
Other languages
English (en)
Inventor
Aaron Noyes
Christopher Gallo
Daniel Lacasse
James Edward Booth
Jason Cormier
Shujun Sun
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of BRPI1009447A2 publication Critical patent/BRPI1009447A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI1009447A 2009-03-11 2010-03-11 métodos de purificação de proteínas imunofarmacêuticas modulares pequenas BRPI1009447A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15934709P 2009-03-11 2009-03-11
PCT/US2010/026931 WO2010147686A2 (en) 2009-03-11 2010-03-11 Methods of purifying small modular immunopharmaceutical proteins

Publications (1)

Publication Number Publication Date
BRPI1009447A2 true BRPI1009447A2 (pt) 2016-03-01

Family

ID=43012630

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009447A BRPI1009447A2 (pt) 2009-03-11 2010-03-11 métodos de purificação de proteínas imunofarmacêuticas modulares pequenas

Country Status (11)

Country Link
US (1) US20120141497A1 (pt)
EP (1) EP2406274A2 (pt)
JP (1) JP2010209068A (pt)
KR (1) KR20110139216A (pt)
CN (1) CN102395597A (pt)
AU (1) AU2010260476A1 (pt)
BR (1) BRPI1009447A2 (pt)
CA (1) CA2751000A1 (pt)
IL (1) IL215082A0 (pt)
RU (1) RU2011137030A (pt)
WO (1) WO2010147686A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ599100A (en) * 2009-10-20 2014-07-25 Abbvie Inc Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
EP2526114B1 (de) * 2010-01-22 2014-06-18 Boehringer Ingelheim International GmbH Chromatographisches verfahren zur aufreinigung von fc enthaltenden proteinen
WO2011156073A1 (en) * 2010-06-08 2011-12-15 Millipore Corporation Removal of protein aggregates from biopharmaceutical preparations using calcium phosphate salts
AR082963A1 (es) 2010-09-17 2013-01-23 Sumitomo Chemical Co Composicion para aerosol de control de plagas
BR112013008738B1 (pt) * 2010-10-11 2017-12-19 Abbvie Bahamas Ltd. Method for purification of a protein
JP6096774B2 (ja) * 2011-08-12 2017-03-15 キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング 核酸を単離するための方法
CN102492040B (zh) * 2011-12-29 2014-06-25 嘉和生物药业有限公司 一种抗her2或/和抗her3抗体蛋白的纯化方法
ES2778033T3 (es) 2012-11-16 2020-08-07 Poseida Therapeutics Inc Enzimas específicas de sitio y métodos de uso
CN102993266B (zh) * 2012-11-30 2019-08-23 广州白云山拜迪生物医药有限公司 一种融合蛋白的纯化和复性方法
PL3395423T3 (pl) * 2013-03-14 2024-03-18 Amgen Inc. Usuwanie wypłukanych ligandów do oczyszczania na zasadzie powinowactwa
AU2014233451B2 (en) * 2013-03-15 2018-07-12 Genzyme Corporation Affinity-based analytical purification of biotherapeutics for bioprocess monitoring
WO2015195798A1 (en) * 2014-06-17 2015-12-23 Poseida Therapeutics, Inc. A method for directing proteins to specific loci in the genome and uses thereof
CA2958144A1 (en) * 2014-08-15 2016-02-18 Oncomed Pharmaceuticals, Inc. Rspo1 binding agents and uses thereof
JP6845139B2 (ja) 2014-12-15 2021-03-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 粗製溶液からの標的分子捕捉
CN104693303B (zh) * 2015-02-28 2018-03-13 苏州金盟生物技术有限公司 一种蛋白制品中的核酸去除方法
JP2018521689A (ja) 2015-06-17 2018-08-09 ポセイダ セラピューティクス, インコーポレイテッド タンパク質をゲノム内の特定の遺伝子座に導くための組成物および方法
JP2019108274A (ja) * 2016-04-18 2019-07-04 昭和電工株式会社 タンパク質凝集体の除去方法
US10814305B2 (en) * 2016-09-29 2020-10-27 Bio-Rad Laboratories, Inc. Agarose-filled ceramic apatite
US11155575B2 (en) 2018-03-21 2021-10-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbent, devices and methods
US20210380638A1 (en) * 2018-12-21 2021-12-09 WuXi Biologics Ireland Limited A method for improving aggregate removal by Protein A chromatography
US20220314142A1 (en) * 2019-07-01 2022-10-06 Pfizer Inc. Improvements to wash solutions for protein a chromatography in an antibody purification process
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
CN115280151A (zh) 2020-01-08 2022-11-01 瑞泽恩制药公司 使用氨基酸增强质谱分析中的信号
WO2021147857A1 (en) * 2020-01-20 2021-07-29 Wuxi Biologics (Shanghai) Co., Ltd A novel wash buffer solution for affinity chromatography
JP7577538B2 (ja) 2020-02-19 2024-11-05 バイオ-ラッド ラボラトリーズ インコーポレーティッド ポリマー充填クロマトグラフィー樹脂を調製する方法
US20230250133A1 (en) * 2022-02-10 2023-08-10 Kodiak Sciences Inc. Methods of purifying a product
CN115894604B (zh) * 2022-12-16 2024-01-23 康日百奥生物科技(苏州)有限公司 重组蛋白澄清纯化方法
CN116120392B (zh) * 2023-04-18 2023-08-01 上海健士拜生物科技有限公司 聚体蛋白的纯化方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
EP1361892A4 (en) 2001-01-17 2004-10-13 Trubion Pharmaceuticals Inc BINDING DOMAIN FUSION PROTEIN Immunoglobulin
US20040058445A1 (en) 2001-04-26 2004-03-25 Ledbetter Jeffrey Alan Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB
JP4599355B2 (ja) 2003-07-28 2010-12-15 ジェネンテック, インコーポレイテッド プロテインaアフィニティークロマトグラフィーの間のプロテインaの浸出の低減
BRPI0415887B1 (pt) * 2003-10-27 2021-01-26 Wyeth métodos para a remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatita
WO2007014238A2 (en) 2005-07-25 2007-02-01 Trubion Pharmaceuticals, Inc. Single dose use of cd20-specific binding molecules
TW200821026A (en) 2006-09-08 2008-05-16 Wyeth Corp Arginine wash in protein purification using affinity chromatography
KR20090069330A (ko) * 2006-10-12 2009-06-30 와이어쓰 유백광/응집체를 감소시키기 위한 항체 용액 중의 이온 강도의 변화
US7846434B2 (en) * 2006-10-24 2010-12-07 Trubion Pharmaceuticals, Inc. Materials and methods for improved immunoglycoproteins
CN101842389A (zh) 2007-06-12 2010-09-22 惠氏有限责任公司 抗cd20治疗组合物和方法
CN105646643A (zh) * 2008-10-29 2016-06-08 阿布林克斯公司 单域抗原结合性分子的纯化方法

Also Published As

Publication number Publication date
RU2011137030A (ru) 2013-04-20
AU2010260476A1 (en) 2011-10-13
KR20110139216A (ko) 2011-12-28
IL215082A0 (en) 2011-11-30
US20120141497A1 (en) 2012-06-07
WO2010147686A3 (en) 2011-02-24
WO2010147686A2 (en) 2010-12-23
CA2751000A1 (en) 2010-12-23
CN102395597A (zh) 2012-03-28
EP2406274A2 (en) 2012-01-18
JP2010209068A (ja) 2010-09-24

Similar Documents

Publication Publication Date Title
IL215082A0 (en) Methods of purifying small modular immunopharmaceutical proteins
DK2598514T3 (da) Proteinoprensning
HUE041436T2 (hu) Tal-effektor-közvetített DNS-módosítás
EP2406399A4 (en) MIRAC PROTEINS
BR112013024521A2 (pt) métodos de purificação de proteínas
PT3056224T (pt) Método de esterilização
DK2307543T3 (da) Forbedret proteinekspressionssystem
IL219715A (en) Sewage treatment apparatus
SMT201500142B (it) Procedimento per la purificazione di proteine
BRPI1015220A2 (pt) purificador de água
EP2519536A4 (en) PROTEIN PURIFICATION BY ION EXCHANGE
DK2273004T3 (da) Rensesystem
BR212012009026U2 (pt) escova de dentes
BRPI0922716A2 (pt) purificação de polipeptídeo
BRPI1009018A2 (pt) fotobiorreator
EP2519537A4 (en) CLEANING PROTEINS
FI20105919A0 (fi) Menetelmä veden puhdistamiseksi
BRPI1010121A2 (pt) método de tratamento biológico
BRPI1015272A2 (pt) Fermentação
BRPI1006155A2 (pt) purificador de água
FI20096202A0 (fi) Biologinen regeneraatti
FR2946103B1 (fr) Support modulaire
IL229383A0 (en) A process for purifying protein with a low acidity level
BRPI0920524A2 (pt) método de purificação
DK2424661T3 (da) Zeolit y

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]